Pivotal Life Sciences

VC San Francisco, United States · Founded 2017

Pivotal Life Sciences is a global healthcare investment firm that supports companies developing high-impact therapeutics to address major unmet medical needs. The firm invests across all stages of development, focusing on transformative solutions nearing key de-risking value inflection points.

About Pivotal Life Sciences

Pivotal Life Sciences (formerly Pivotal bioVenture Partners or related entities) is a healthcare-specialist investment firm focused on life sciences, with deep exposure across biotech, drug discovery, therapeutics platforms and adjacent science-driven healthcare opportunities. The firm’s positioning emphasizes science-led diligence, multi-stage participation across crossover and growth rounds, and partnerships with institutional life-sciences investors on syndicates leading toward IPO. Check sizes are typically meaningful, plausibly in the $5M to $30M range across Series B, C and crossover rounds, with capacity to participate in IPO-stage financings. For healthcare founders, Pivotal is highly relevant if you are a clinical-stage therapeutics or platform company with proven science, a credible regulatory path and a fundraising trajectory toward IPO, where a science-specialist crossover-style investor adds capital, syndicate quality and exit credibility. The firm is a poor fit for digital health, healthcare services, healthcare IT, AI-only software, consumer health and pre-clinical or seed-stage life-sciences companies. Founders should expect rigorous scientific diligence, demanding board engagement and well-formed views on clinical and corporate strategy. Entry is best via warm introductions from existing life-sciences VC syndicate members, sector-focused investment bankers, scientific advisors with sector relationships, or current portfolio CEOs. Cold outbound is significantly less effective in late-stage life sciences; a co-investor introduction is effectively the standard entry path. Founders should clarify fund stage, position size preference and exit timeline expectations early in any conversation.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Pivotal Life Sciences

Tools made by companies in Pivotal Life Sciences's portfolio that we cover in the directory.

Exscientia AI-driven
Exscientia
Drug Discovery & Research
Recursion, integrating Exscientia's AI platform, pioneers AI-driven drug discovery using automated chemistry, deep learning, and robotics to accelerate the development of novel therapeutics.

Portfolio companies in our directory

Other portfolio companies

Companies in Pivotal Life Sciences's portfolio not currently in our directory.

Team

Vincent Cheung
Chairman
Rob Hopfner
Managing General Partner
Peter Bisgaard
Managing Partner
Tony Ho
Partner
Glenn Batchelder
Partner
Mischa Travers
US Chief Operating Officer and General Counsel

Pitch / review this investor

Have you raised from Pivotal Life Sciences? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.